Human Phenotype Ontology 
Grandparent Node:
expand
Decreased body weight (HP:0004325)help
Parent Node:
expand
Weight loss (HP:0001824)help
..Starting node
..expand
Cachexia (HP:0004326)help
Term ID: 4326
Name: Cachexia
Synonym: Wasting syndrome
Definition: Severe weight loss, wasting of muscle, loss of appetite, and general debility related to a chronic disease.
Comments:
Reference: HP:0004326
Genes and Diseases:
 
       Child Nodes:

 Sister Nodes: 
InputHPO IDHPO termDistanceGeneGene id entrezDiseaseIdDiseaseNameDiseaseMIMConceptIDSourceTypical associationHGMD variantsClinVar variantsHGNC IDGeneMIM
 
HPO disease - gene - phenotype typical associations:
HP:0004326HP:0004326Cachexia0AKT1 CL E G H207744Aortic valves stenosis of the childORPHA1758391164730
HP:0004326HP:0004326Cachexia0ATR CL E G H545808Baker Vinters syndromeORPHA12965882601215
HP:0004326HP:0004326Cachexia0ATRIP CL E G H84126808Baker Vinters syndromeORPHA157633499606605
HP:0004326HP:0004326Cachexia0CENPE CL E G H1062808Baker Vinters syndromeORPHA13501856117143
HP:0004326HP:0004326Cachexia0CENPJ CL E G H55835808Baker Vinters syndromeORPHA157417272609279
HP:0004326HP:0004326Cachexia0CEP152 CL E G H22995808Baker Vinters syndromeORPHA159529298613529
HP:0004326HP:0004326Cachexia0COL12A1 CL E G H1303610Alopecia macular degeneration growth retardationORPHA125482188120320
HP:0004326HP:0004326Cachexia0COL6A1 CL E G H1291610Alopecia macular degeneration growth retardationORPHA117182211120220
HP:0004326HP:0004326Cachexia0COL6A2 CL E G H1292610Alopecia macular degeneration growth retardationORPHA119282212120240
HP:0004326HP:0004326Cachexia0COL6A3 CL E G H1293610Alopecia macular degeneration growth retardationORPHA130012213120250
HP:0004326HP:0004326Cachexia0CUL4B CL E G H845085293ORPHA14152555300304
HP:0004326HP:0004326Cachexia0ERCC2 CL E G H2068220295ORPHA115723434126340
HP:0004326HP:0004326Cachexia0ERCC3 CL E G H2071220295ORPHA15233435133510
HP:0004326HP:0004326Cachexia0ERCC4 CL E G H2072220295ORPHA17263436133520
HP:0004326HP:0004326Cachexia0ERCC4 CL E G H2072610965XFE progeroid syndrome610965C1970416OMIM17263436133520
HP:0004326HP:0004326Cachexia0ERCC5 CL E G H2073220295ORPHA14913437133530
HP:0004326HP:0004326Cachexia0INSR CL E G H3643508Acroosteolysis dominant typeORPHA16226091147670
HP:0004326HP:0004326Cachexia0LIPA CL E G H398875233ORPHA15616617613497
HP:0004326HP:0004326Cachexia0LPIN2 CL E G H966377297ORPHA193114450605519
HP:0004326HP:0004326Cachexia0MAFB CL E G H99352774Hydrocephalus growth retardation skeletal anomaliesORPHA11536408608968
HP:0004326HP:0004326Cachexia0MECP2 CL E G H4204312750Rett syndrome312750C0035372OMIM119256990300005
HP:0004326HP:0004326Cachexia0MT-CO1 CL E G H4512550ORPHA17419516030
HP:0004326HP:0004326Cachexia0MT-CO2 CL E G H4513550ORPHA17421516040
HP:0004326HP:0004326Cachexia0MT-CO3 CL E G H4514550ORPHA17422516050
HP:0004326HP:0004326Cachexia0MT-ND1 CL E G H4535550ORPHA17455516000
HP:0004326HP:0004326Cachexia0MT-ND4 CL E G H4538550ORPHA17459516003
HP:0004326HP:0004326Cachexia0MT-ND5 CL E G H4540550ORPHA17461516005
HP:0004326HP:0004326Cachexia0MT-ND6 CL E G H4541550ORPHA17462516006
HP:0004326HP:0004326Cachexia0MT-TF CL E G H4558550ORPHA17481590070
HP:0004326HP:0004326Cachexia0MT-TH CL E G H4564550ORPHA17487590040
HP:0004326HP:0004326Cachexia0MT-TL1 CL E G H4567550ORPHA17490590050
HP:0004326HP:0004326Cachexia0MT-TQ CL E G H4572550ORPHA17495590030
HP:0004326HP:0004326Cachexia0MT-TS1 CL E G H4574550ORPHA17497590080
HP:0004326HP:0004326Cachexia0MT-TS2 CL E G H4575550ORPHA17498590085
HP:0004326HP:0004326Cachexia0MT-TW CL E G H4578550ORPHA17501590095
HP:0004326HP:0004326Cachexia0NBN CL E G H4683647ORPHA132507652602667
HP:0004326HP:0004326Cachexia0PCNT CL E G H5116808Baker Vinters syndromeORPHA1200116068605925
HP:0004326HP:0004326Cachexia0PLA2G6 CL E G H839835069ORPHA17759039603604
HP:0004326HP:0004326Cachexia0PLK4 CL E G H10733808Baker Vinters syndromeORPHA156811397605031
HP:0004326HP:0004326Cachexia0POLG CL E G H5428603041Mitochondrial DNA depletion syndrome 1 (MNGIE type)603041C0872218OMIM123249179174763
HP:0004326HP:0004326Cachexia0POLG CL E G H5428613662Mitochondrial DNA depletion syndrome 4B, MNGIE type613662C3150914OMIM123249179174763
HP:0004326HP:0004326Cachexia0POLG CL E G H5428298Mitochondrial neurogastrointestinal encephalomyopathyCN918676ORPHA123249179174763
HP:0004326HP:0004326Cachexia0PTEN CL E G H5728744Aortic valves stenosis of the childORPHA130129588601728
HP:0004326HP:0004326Cachexia0RBBP8 CL E G H5932808Baker Vinters syndromeORPHA13249891604124
HP:0004326HP:0004326Cachexia0RRM2B CL E G H50484612075Mitochondrial DNA depletion syndrome, encephalomyopathic form, with renal tubulopathy612075C2749861OMIM135417296604712
HP:0004326HP:0004326Cachexia0RRM2B CL E G H50484298Mitochondrial neurogastrointestinal encephalomyopathyCN918676ORPHA135417296604712
HP:0004326HP:0004326Cachexia0SLC6A8 CL E G H653552503ORPHA1106211055300036
HP:0004326HP:0004326Cachexia0SLC9A6 CL E G H1047985278ORPHA161211079300231
HP:0004326HP:0004326Cachexia0SUCLA2 CL E G H88031933ORPHA141311448603921
HP:0004326HP:0004326Cachexia0TGFB1 CL E G H70401328Chromosome 15 ringCN035931ORPHA128611766190180
HP:0004326HP:0004326Cachexia0TRAIP CL E G H10293808Baker Vinters syndromeORPHA111930764605958
HP:0004326HP:0004326Cachexia0TRIM37 CL E G H45912576Grubben de Cock Borghgraef syndromeORPHA13747523605073
HP:0004326HP:0004326Cachexia0TRPV4 CL E G H593411216ORPHA1101818083605427
HP:0004326HP:0004326Cachexia0TYMP CL E G H1890603041Mitochondrial DNA depletion syndrome 1 (MNGIE type)603041C0872218OMIM18953148131222
HP:0004326HP:0004326Cachexia0TYMP CL E G H1890298Mitochondrial neurogastrointestinal encephalomyopathyCN918676ORPHA18953148131222
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0004326HP:0004326Cachexia0COL1A1 CL E G H1277287ORPHA024282197120150
HP:0004326HP:0004326Cachexia0COL5A1 CL E G H1289287ORPHA029092209120215
HP:0004326HP:0004326Cachexia0COL5A2 CL E G H1290287ORPHA015132210120190
HP:0004326HP:0004326Cachexia0EWSR1 CL E G H213083469ORPHA0743508133450
HP:0004326HP:0004326Cachexia0HSPG2 CL E G H3339800ORPHA024975273142461
HP:0004326HP:0004326Cachexia0LMNA CL E G H4000157973ORPHA018146636150330
HP:0004326HP:0004326Cachexia0NDP CL E G H4693649ORPHA02997678300658
HP:0004326HP:0004326Cachexia0PTEN CL E G H5728109Bannayan-Riley-Ruvalcaba syndromeC0265326ORPHA030129588601728
HP:0004326HP:0004326Cachexia0SLC52A2 CL E G H7958197229ORPHA052030224607882
HP:0004326HP:0004326Cachexia0SLC52A3 CL E G H11327897229ORPHA046416187613350
HP:0004326HP:0004326Cachexia0UNC80 CL E G H285175616801Hypotonia, infantile, with psychomotor retardation and characteristic facies 2616801C4225203OMIM0181626582612636
HP:0004326HP:0004326Cachexia0WT1 CL E G H749083469ORPHA0137112796607102


Genes (75) :AKT1 ATR ATRIP CENPE CENPJ CEP152 COL12A1 COL1A1 COL5A1 COL5A2 COL6A1 COL6A2 COL6A3 COX1 COX2 COX3 CUL4B ERCC2 ERCC3 ERCC4 ERCC5 EWSR1 HSPG2 INSR LIPA LMNA LPIN2 MAFB MECP2 MT-CO1 MT-CO2 MT-CO3 MT-ND1 MT-ND4 MT-ND5 MT-ND6 MT-TF MT-TH MT-TL1 MT-TQ MT-TS1 MT-TS2 MT-TW NBN ND1 ND4 ND5 ND6 NDP PCNT PLA2G6 PLK4 POLG PTEN RBBP8 RRM2B SLC52A2 SLC52A3 SLC6A8 SLC9A6 SUCLA2 TGFB1 TRAIP TRIM37 TRNF TRNH TRNL1 TRNQ TRNS1 TRNS2 TRNW TRPV4 TYMP UNC80 WT1

Diseases (32) :744 808 610 287 550 85293 220295 610965 83469 800 508 75233 157973 77297 2774 312750 647 649 35069 603041 613662 298 109 612075 97229 52503 85278 1933 1328 2576 1216 616801
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is August 2021 release.